Abstract
Amivantamab (amivantamab-vmjw; Rybrevant (TM)), a bispecific monoclonal antibody targeting epidermal growth factor receptor (EGFR) and mesenchymal epi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
